SCHEMBL4306387

SCHEMBL4306387

CCCc1cc(=O)[nH]c(C)n1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.66
SMN1; SMN2 Q16637 4/20 0.65
CYP1A2 P05177 1/20 0.60
MAPT P10636 8/20 0.56
ALDH1A1 P00352 4/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TP53 P04637 2/20 0.51
HSD17B10 Q99714 2/20 0.51
GAA P10253 3/20 0.50
HPGD P15428 3/20 0.50
HTT P42858 2/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
XBP1 P17861 1/20 0.48
ATM Q13315 1/20 0.48
NAMPT P43490 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15107929 0.84 SMN1; SMN2 (0.69) BACE1SMN1; SMN2CYP1A2MAPTALDH1A1
SCHEMBL4809195 0.79 BACE1 (1.00) BACE1SMN1; SMN2CYP1A2MAPTALDH1A1
Propylthiouracil SCHEMBL4537771 0.79 BACE1 (0.64) BACE1SMN1; SMN2CYP1A2MAPTALDH1A1
SCHEMBL9414223 0.77 BACE1 (0.60) BACE1SMN1; SMN2CYP1A2MAPTALDH1A1
SCHEMBL2786194 0.77 CYP1A2 (0.73) BACE1SMN1; SMN2CYP1A2MAPTALDH1A1
SCHEMBL26063171 0.73 CYP1A2 (0.77) SMN1; SMN2CYP1A2MAPTALDH1A1NPSR1
SCHEMBL26064133 0.73 CYP1A2 (0.68) BACE1SMN1; SMN2CYP1A2MAPTALDH1A1
SCHEMBL1895087 0.72 BACE1 (0.54) BACE1SMN1; SMN2CYP1A2MAPTALDH1A1
SCHEMBL26039927 0.72 CYP1A2 (0.75) SMN1; SMN2CYP1A2MAPTALDH1A1NPSR1
SCHEMBL1892022 0.71 HTT (0.67) BACE1SMN1; SMN2CYP1A2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024103188-A1 LIN28 INHIBITORS AND USES THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2024-05-23 WO disclosed
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed